Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Seattle, WA
SEC filing record 1 source field available
Fiscal year end
31 December
ATOSSA THERAPEUTICS, INC. has filed 636 SEC EDGAR filings since 30 Mar 2010

SEC filing history

Showing 201-225 of 636 matching filings.

Per page
25
Current page
9
S-8 File 333-254905

FORM S-8

Filing date
31 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35610

FORM 8-K

Filing date
31 Mar 2021
Reporting date
31 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-248555

FORM 424B5

Filing date
23 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35610

FORM 8-K

Filing date
23 Mar 2021
Reporting date
22 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3MEF File 333-254548

FORM S-3MEF

Filing date
22 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35610

FORM 8-K

Filing date
22 Mar 2021
Reporting date
22 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B2 File 333-252335

FORM 424B2

Filing date
04 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-252335

EFFECT filing

Filing date
29 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
28 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
28 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-252335

FORM S-3

Filing date
22 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87057

SCHEDULE 13G

Filing date
15 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87057

SC 13G

Filing date
15 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87057

SC 13G/A

Filing date
15 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87057

ATOSSA THERAPEUTICS, INC.

Filing date
14 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-248555

FORM 424B3

Filing date
08 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35610

FORM 8-K

Filing date
08 Jan 2021
Reporting date
06 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87057

SCHEDULE 13G

Filing date
28 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-248555

FORM 424B5

Filing date
21 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35610

FORM 8-K

Filing date
21 Dec 2020
Reporting date
17 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87057

SC 13G

Filing date
18 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35610

FORM 8-K

Filing date
14 Dec 2020
Reporting date
08 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-250820

FORM 424B3

Filing date
11 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-250820

EFFECT filing

Filing date
08 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .